Akademik Veri Yönetim Sistemi
Revista da Associacao Medica Brasileira, cilt.72, sa.1, 2026 (SCI-Expanded, Scopus)
OBJECTIVE: The aim of this study was to investigate the effect of gamified breastfeeding education on breastfeeding self-efficacy and infant feeding attitudes of pregnant women. METHODS: A total of 60 primiparous women in the third trimester of pregnancy were randomly assigned to experimental (n=30) and control (n=30) groups. Data were collected using the Sociodemographic and Obstetric Characteristics Form, Breastfeeding Self-Efficacy Scale-Antenatal Form, and the Iowa Infant Feeding Attitude Scale. The experimental group received a gamified breastfeeding education program designed by the researchers and developed based on Werbach and Hunter’s D6 Gamification Framework. The program was delivered via a secure Web 2.0 platform and included the interactive digital game “Discovering Breastfeeding” and an educational escape room-style activity enriched with visual and auditory elements. The intervention aimed to enhance participants’ motivation, engagement, and learning through game mechanics such as goals, feedback, challenges, and rewards. The control group received routine hospital antenatal education. Pretest and posttest data were analyzed using appropriate statistical methods. RESULTS: No significant difference was found between the groups in baseline measurements. However, post-test scores revealed that women in the experimental group showed a significant improvement in both breastfeeding self-efficacy and infant feeding attitudes compared to the control group (p<0.05). Effect sizes indicated a strong impact of the intervention. CONCLUSION: Gamified breastfeeding education based on digital and interactive learning principles effectively enhanced pregnant women’s self-efficacy and attitudes toward infant feeding. Incorporating gamification into maternal health education may increase motivation, promote positive behavioral change, and contribute to better breastfeeding outcomes for mothers and infants. The trial was registered in the clinicaltrials.gov notification system.